Shots:

• The integration of real-time CGM data into the smart insulin pen app follows the acquisition of Companion Medical's InPen to the Medtronic portfolio- as of Sept’2020
• The integrated system provides real-time glucose readings alongside insulin dose information giving users everything they need to manage their diabetes through a single smartphone app
• InPen is the first and only FDA-cleared smart2 insulin pen on the market for people on MDI. The InPen app will continue to display information from other compatible CGM systems on a three-hour delay

­  Ref: Medtronic | Image: Medical Product Outsourcing